New Article: Barak et al, Where to Die? A Study of Cancer Patients in Israel

Barak, Frida, Sofia Livshits, Haana Kaufer, Ruth Netanel, Nava Siegelmann-Danieli, Yasmin Alkalay, and Shulamith Kreitler. “Where to Die? That Is the Question: A Study of Cancer Patients in Israel.” Palliative and Supportive Care 13.2 (2015): 165-70.

 

URL: http://dx.doi.org/10.1017/S1478951513000904

 

Abstract

Objective: Most patients prefer to die at home, but barely 30% do so. This study examines the variables contributing to dying at home.

Methods: The participants were 326 cancer patients, of both genders, with a mean age of 63.25 years, who died from 2000 to 2008 and were treated by the palliative care unit of the Barzilai Hospital. Some 65.7% died at home and 33.4% in a hospital. The data were extracted from patient files. The examined variables were demographic (e.g., age, gender, marital status, ethnic background, number of years in Israel until death), medical (e.g., age at diagnosis, diagnosis, nature of last treatment, patient received nursing care, patient given the care of a social worker, patient had care of a psychologist, family received care of a social worker, patient had a special caregiver), and sociological (e.g., having insurance, having worked in Israel, living alone or with family, living with one’s children, living in self-owned or rented house, family members working).

Results: The findings indicate that the chances of dying at home are higher if the patient is non-Ashkenazi, the family got social worker care, the patient lived in a self-owned house, the patient lived with his family, the family members worked, and the patient’s stay in Israel since immigration was longer. Logistic regression showed that all the predictors together yielded a significant model accounting for 10.9–12.3% of the variance.

Significance of results: The findings suggest that dying at home requires maintaining continued care for the patient and family in a community context.

New Article: Ben Arye et al, Perspectives of Arab Patients in Palestine and Israel on the Role of Complementary Medicine

Ben-Arye, Eran, Amneh M.A. Hamadeh, Elad Schiff, Rana M. Jamous, Jamal Dagash, Rania M. Jamous, Abed Agbarya, Gil Bar-Sela, Eyas Massalha, Michael Silbermann, and Mohammed Saleem Ali-Shtayeh. “Compared Perspectives of Arab Patients in Palestine and Israel on the Role of Complementary Medicine in Cancer Care.” Journal of Pain and Symptom Management 49.5 (2015): 878-84.

 

URL: http://dx.doi.org/10.1016/j.jpainsymman.2014.10.006

 

Abstract

Context

Complementary medicine (CM) is extensively used by patients with cancer across the Middle East.

Objectives

We aimed to compare the perspectives of two Arab populations residing in diverse socioeconomic-cultural settings in Palestine and Israel regarding the role of CM in supportive cancer care.

Methods

A 27-item questionnaire was constructed and administered to a convenience sample of Arab patients receiving cancer care in four oncology centers in northern Israel and Palestine.

Results

Each of the two groups had 324 respondents and was equally distributed by age and marital status. Compared with the Israeli-Arab group, Palestinian participants reported significantly higher CM use for cancer-related outcomes (63.5% vs. 39.6%, P < 0.001), which included more herbal use (97.6% vs. 87.9%, P = 0.001) and significantly lower use of dietary supplements, acupuncture, mind-body and manual therapies, and homeopathy. Most respondents in both groups stated that they would consult CM providers if CM was integrated in oncology departments. Related to this theoretical integrative scenario, Palestinian respondents expressed fewer expectations from their oncologists to actively participate in building their CM treatment plan. Treatment expectations in both groups focused on improving quality of life (QOL), whereas Palestinian respondents had fewer expectations for CM to improve fatigue, emotional concerns, sleep, and daily functioning.

Conclusion

Arab patients with cancer from Palestine and Israel highly support CM integration within their oncology institutions aiming to improve QOL. Nevertheless, respondents differed in their perceived model of CM integration, its treatment objectives, and their oncologists’ role in CM integration.

New Article: Abu-Raiya et al, Religious Coping and Social Support for Israeli Muslim Parents of Children with Cancer

Abu-Raiya, Hisham, Liat Hamama, and Fatima Fokra. “Contribution of Religious Coping and Social Support to the Subjective Well-Being of Israeli Muslim Parents of Children with Cancer: A Preliminary Study.” Health & Social Work (early view; online first).

 

URL: http://dx.doi.org/10.1093/hsw/hlv031

 

Abstract

No single study has examined the subjective well-being (SWB) among Israeli Muslim parents of children treated for cancer. To fill this gap in the literature, this preliminary study espouses a positive psychology orientation and examines the contribution of social support and religious coping to the SWB among this population. The study’s sample consisted of 70 Israeli Muslim parents of children who were receiving active treatment for their cancer. Participants were asked to provide demographic information on themselves and their ill child and to complete measures of SWB (that is, positive affect, negative affect, satisfaction with life), social support, and religious coping (that is, positive religious coping, punishing God reappraisal). The authors found that higher scores on social support were correlated with higher scores on satisfaction with life and lower scores on negative affect. Higher scores on positive religious coping were correlated with higher scores on satisfaction with life. Punishing God reappraisal did not correlate with any of the SWB indices. Social support emerged as a partial mediator between positive religious coping and satisfaction with life. Social support and some methods of religious coping seem to enhance the SWB of Israeli Muslim parents of children treated for cancer.

New Article: Kadmon et al, Perceptions of Israeli Women with Breast Cancer Regarding the Role of the Breast Care Nurse

Kadmon, Ilana, Hana Halag, ,Irit Dinur, Aliza Katz, Hana Zohar, Myra Damari, Malka Cohen, Elite Levin, Livia Kislev. “Perceptions of Israeli Women with Breast Cancer Regarding the Role of the Breast Care Nurse throughout All Stages of Treatment: A Multi Center Study.” European Journal of Oncology Nursing 19.1 (2015): 38-43. 

 

URL: http://dx.doi.org/10.1016/j.ejon.2014.07.014

 

Abstract

Purpose of the research

The role of the Breast Care Nurse (BCN) is well established in Israel. The purpose of this study is to examine the impact of the BCN on Israeli women with breast cancer at all stages of disease from diagnosis, through treatment and follow-up.

Methods

This was a descriptive multi-center study on 321 women with non-metastatic breast cancer who completed their treatment <5 years before. Data collection took place in seven institutions in Israel, both in hospital and in the community. The women completed two questionnaires: a demographic questionnaire and the Ipswitch Patient Questionnaire looking at various aspects of care. Also included was one qualitative open question. Data analysis was performed checking for outliers and illogical observations.

Key results

In most areas investigated the women perceived the overall contribution of the BCN as very high, with 87% reporting a general contribution of very high or high. It was found that 53% of the women received information about the position from the nurse herself. In 61.3% of the cases, initial contact with the BCN was made at the time of diagnosis.

The qualitative findings concerning the open question are also reported.

Conclusions

According to the perceptions of women with breast cancer in Israel, BCN support is an important part of the patient’s ability to manage their diagnosis and related care. The multi-disciplinary breast cancer team should incorporate BCN specialists as part of their holistic care.

New Article: Waissengrin et al, Patterns of Use of Medical Cannabis Among Israeli Cancer Patients

Waissengrin, Barliz, Damien Urban, Yasmin Leshem, Meital Garty, and Ido Wolf. “Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience.” Journal of Pain and Symptom Management 49.2 (2015): 223-30.

 

URL: http://dx.doi.org/10.1016/j.jpainsymman.2014.05.018

 

Abstract

Context

The use of the cannabis plant (Cannabis sativa L.) for the palliative treatment of cancer patients has been legalized in multiple jurisdictions including Israel. Yet, not much is currently known regarding the efficacy and patterns of use of cannabis in this setting.

Objectives

To analyze the indications for the administration of cannabis among adult Israeli cancer patients and evaluate its efficacy.

Methods

Efficacy and patterns of use of cannabis were evaluated using physician-completed application forms, medical files, and a detailed questionnaire in adult cancer patients treated at a single institution.

Results

Of approximately 17,000 cancer patients seen, 279 (<1.7%) received a permit for cannabis from an authorized institutional oncologist. The median age of cannabis users was 60 years (range 19–93 years), 160 (57%) were female, and 234 (84%) had metastatic disease. Of 151 (54%) patients alive at six months, 70 (46%) renewed their cannabis permit. Renewal was more common among younger patients and those with metastatic disease. Of 113 patients alive and using cannabis at one month, 69 (61%) responded to the detailed questionnaire. Improvement in pain, general well-being, appetite, and nausea were reported by 70%, 70%, 60%, and 50%, respectively. Side effects were mild and consisted mostly of fatigue and dizziness.

Conclusion

Cannabis use is perceived as highly effective by some patients with advanced cancer and its administration can be regulated, even by local authorities. Additional studies are required to evaluate the efficacy of cannabis as part of the palliative treatment of cancer patients.